Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Barboy O, Bercovich A, Li H, Eyal-Lubling Y, Yalin A, Shapir Itai Y, Abadie K, Zada M, David E, Shlomi-Loubaton S, Katzenelenbogen Y, Jaitin DA, Gur C, Yofe I, Feferman T, Cohen M, Dahan R, Newell EW, Lifshitz A, Tanay A, Amit I.
Barboy O, et al. Among authors: dahan r.
Nat Cancer. 2024 May;5(5):742-759. doi: 10.1038/s43018-024-00734-z. Epub 2024 Mar 1.
Nat Cancer. 2024.
PMID: 38429414